Growth and expansion Gelteq’s rapid expansion into veterinary medicine, human clinical trials, and GPS-backed API pipeline indicates a need for scalable CRO/clinical trial management, regulatory consulting, and outsourced development services to support accelerating programs.

Financial scale With revenue in the mid tens of millions and a strategic debt facility of up to 3.5 million, there is opportunity to cross-sell financial workflow tools, cashflow optimization services, or advisory offerings for biotech-adjacent finance and risk management.

Global footprint Establishing a Center of Excellence in Guangdong and commercial activity in East Asia signal demand for regional supply chain, manufacturing scalability, and region-specific regulatory navigation support.

Tech-enabled Gelteq’s tech stack and emphasis on advanced delivery platforms present a chance to offer integration consulting, data analytics, and optimization of digital workflows for GMP quality systems and R&D data management.

Strategic partnerships Ongoing collaborations with Kemin and other partners, plus a veterinary pilot pipeline, create openings for channel partnerships, co-marketing arrangements, and bundled solutions combining formulation, manufacturing, and regulatory pathways.